Clinical Trials Directory

Trials / Completed

CompletedNCT04190147

Eye and Growth in Adolescents Born Moderate-to-late Preterm

Ocular Morphology and Visual Function in Relation to Growth, Metabolic, Cardiovascular, and Neuropsychiatric Status, and Quality of Life in Adolescents Born Moderate-to-late Preterm

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Vastra Gotaland Region · Other Government
Sex
All
Age
15 Years – 17 Years
Healthy volunteers
Accepted

Summary

During recent years, the interest in studying the risks of being born moderate-to-late preterm (MLP), defined as birth between gestational week 32 to 36, has increased. Today the investigators know that morbidity and mortality are significantly higher in these individuals compared to individuals born full-term. However, few studies have focused on the development of the eye in MLP individuals. The purpose of the study is to evaluate eye morphology and visual function in relation to growth, metabolism, blood pressure, neuropsychiatric factors, and quality of life in adolescents born MLP. The results of the examinations will be compared to an age-matched control group. The study will evaluate the structural, functional, and metabolic aspects of the eye with the hypothesis that early eye abnormalities may detect the risk of developing metabolic and cardiovascular diseases.

Conditions

Interventions

TypeNameDescription
OTHERStructural, functional and metabolic eye examinationsStructural, functional and metabolic eye examinations

Timeline

Start date
2019-10-28
Primary completion
2021-10-01
Completion
2021-10-01
First posted
2019-12-09
Last updated
2022-05-06

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT04190147. Inclusion in this directory is not an endorsement.